SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-032898
Filing Date
2024-04-15
Accepted
2024-04-15 14:19:26
Documents
85
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0203811-10k_bioessence.htm   iXBRL 10-K 710438
2 DESCRIPTION OF SECURITIES ea020381101ex4-2_bioessence.htm EX-4.2 4780
3 CERTIFICATION ea020381101ex31-1_bioessence.htm EX-31.1 12155
4 CERTIFICATION ea020381101ex31-2_bioessence.htm EX-31.2 11849
5 CERTIFICATION ea020381101ex32-1_bioessence.htm EX-32.1 5297
6 CERTIFICATION ea020381101ex32-2_bioessence.htm EX-32.2 5729
7 GRAPHIC image_001.jpg GRAPHIC 53365
  Complete submission text file 0001213900-24-032898.txt   5178799

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE bioe-20231231.xsd EX-101.SCH 58137
9 XBRL CALCULATION FILE bioe-20231231_cal.xml EX-101.CAL 61635
10 XBRL DEFINITION FILE bioe-20231231_def.xml EX-101.DEF 250895
11 XBRL LABEL FILE bioe-20231231_lab.xml EX-101.LAB 463163
12 XBRL PRESENTATION FILE bioe-20231231_pre.xml EX-101.PRE 247041
89 EXTRACTED XBRL INSTANCE DOCUMENT ea0203811-10k_bioessence_htm.xml XML 485980
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56263 | Film No.: 24844228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)